Login / Signup

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease.

Daniel O ClaassenBenjamin CarrollLisa M De BoerEric WuRajeev AyyagariSanjay GandhiDavid Stamler
Published in: Journal of clinical movement disorders (2017)
ClinicalTrials.gov NCT01795859 and NCT00219804.
Keyphrases
  • open label
  • randomized controlled trial
  • double blind